Literature DB >> 7399670

Cell-mediated immunoprotection in blastomycosis.

G C Cozad, C T Chang.   

Abstract

Delayed hypersensitivity can be induced in C57BL/6J mice by two subcutaneous injections of Merthiolate-killed Blastomyces dermatitidis yeast cells in Freund incomplete adjuvant. Development of delayed hypersensitivity peaked at the day 18 post-primary antigen-emulsion injection, as determined by footpad sensitivity tests. Mice rendered hypersensitive to B. dermatitidis were protected from the lethal effect of a blastomyces infection. The protection effects were shown both in mortality tests and in data from organ cultures as expressed by indices of resistance. Data from this study show that there is a close parallel relationship between host resistance and the prevailing level of delayed hypersensitivity.

Entities:  

Mesh:

Year:  1980        PMID: 7399670      PMCID: PMC550948          DOI: 10.1128/iai.28.2.398-403.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Resistance to reinfection in experimental histoplasmosis.

Authors:  S B SALVIN
Journal:  J Immunol       Date:  1955-03       Impact factor: 5.422

2.  Immunization of mice with viable Cocidioides immitis.

Authors:  D PAPPAGIANIS; H B LEVINE; C E SMITH; R J BERMAN; G S KOBAYASHI
Journal:  J Immunol       Date:  1961-01       Impact factor: 5.422

3.  Immunogenicity of spherule-endospore vaccines of Coccidioides immitis for mice.

Authors:  H B LEVINE; J M COBB; C E SMITH
Journal:  J Immunol       Date:  1961-08       Impact factor: 5.422

4.  Effect of prior vaccination on experimental blastomycosis.

Authors:  M E Landay; M Hotchi; N Soares
Journal:  Mycopathol Mycol Appl       Date:  1972-01-26

5.  The host response to Calmette-Guérin bacillus infection in mice.

Authors:  R V Blanden; M J Lefford; G B Mackaness
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

Review 6.  The relationship of delayed hypersensitivity to acquired cellular resistance.

Authors:  G B Mackaness
Journal:  Br Med Bull       Date:  1967-01       Impact factor: 4.291

7.  Immunologic impairment in mice treated intravenously with killed Coccidioides immitis spherules: suppressed response to intramuscular doses.

Authors:  H B Levine; Y C Kong
Journal:  J Immunol       Date:  1966-09       Impact factor: 5.422

8.  Nature of the skin-reactive principle in culture filtrates prepared from Paracoccidioides brasiliensis.

Authors:  A Restrepo-Moreno; J D Schneidau
Journal:  J Bacteriol       Date:  1967-06       Impact factor: 3.490

9.  Allergenicity of mycobacterial ribosomal and ribonucleic acid preparations in mice and guinea pigs.

Authors:  G P Youmans; A S Youmans
Journal:  J Bacteriol       Date:  1969-01       Impact factor: 3.490

10.  Specific and non-specific immunity in experimental cryptococcosis in mice.

Authors:  D B LOURIA
Journal:  J Exp Med       Date:  1960-05-01       Impact factor: 14.307

View more
  11 in total

1.  Interleukin 12 as an adjuvant to WI-1 adhesin immunization augments delayed-type hypersensitivity, shifts the subclass distribution of immunoglobulin G antibodies, and enhances protective immunity to Blastomyces dermatitidis infection.

Authors:  M Wüthrich; B E Finkel-Jiminez; B S Klein
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

2.  T-Cell epitopes and human leukocyte antigen restriction elements of an immunodominant antigen of Blastomyces dermatitidis.

Authors:  W L Chang; R G Audet; B D Aizenstein; L H Hogan; R I DeMars; B S Klein
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  In vitro susceptibility of fungi to killing by neutrophil granulocytes discriminates between primary pathogenicity and opportunism.

Authors:  A Schaffner; C E Davis; T Schaffner; M Markert; H Douglas; A I Braude
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

4.  Host defence to pulmonary mycosis.

Authors:  C H Mody; P W Warren
Journal:  Can J Infect Dis       Date:  1999-03

5.  WI-1, a novel 120-kilodalton surface protein on Blastomyces dermatitidis yeast cells, is a target antigen of cell-mediated immunity in human blastomycosis.

Authors:  B S Klein; P M Sondel; J M Jones
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

6.  Protection against pulmonary blastomycosis: correlation with cellular and humoral immunity in mice after subcutaneous nonlethal infection.

Authors:  P A Morozumi; E Brummer; D A Stevens
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

7.  Immunogenicity and protective efficacy of the WI-1 adhesin of Blastomyces dermatitidis.

Authors:  M Wüthrich; W L Chang; B S Klein
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

8.  Immunomodulation by Blastomyces dermatitidis: functional activity of murine peritoneal macrophages.

Authors:  L S McDaniel; G C Cozad
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

9.  Blastomycosis during pregnancy.

Authors:  L Daniel; I E Salit
Journal:  Can Med Assoc J       Date:  1984-10-01       Impact factor: 8.262

10.  Blastomyces dermatitidis antigen-induced lymphocytes reactivity in human blastomycosis.

Authors:  R W Bradsher; R H Alford
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.